June #188 : TasP Movement Gains Momentum - by Benjamin Ryan

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents


The Sound of Stigma

Artful Warriors

From the Editor

We Are Family


Letters-June 2013


Out of the Shadows

POZ Planet

Beyond the Pale

Koch vs. Koop

The New 'Normal'

Fountain of Youth

National HIV Coming Out Day?

To Be Continued

In the Beginning



Immigration Status

Care and Treatment

GMHC Treatment Issues June 2013

Generics Save Money but May Come With Risks

TasP Movement Gains Momentum

PIs in First Trimester Linked to Premature Births

Child 'Functionally Cured' of HIV?

Research Notes

Prevention: New Understanding of Old Vaccine

Treatment: CD4 Tests Needed Only Yearly?

Cure: Gene Therapy Has HIV in a Bind

Concerns: Health Threats Outside of AIDS

POZ Survey Says

The Doctor Is In

POZ Heroes


Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

email print

June 2013

TasP Movement Gains Momentum

by Benjamin Ryan

Research is suggesting with increasing clarity and certainty that successful antiretroviral (ARV) treatment is a highly effective means of preventing HIV.

Treatment as prevention (TasP) got a boost earlier this year when England’s Expert Advisory Groupon AIDS (EAGA) and the British HIV Association (BHIVA) published a position paper calling vaginal transmission risk “extremely low” when the HIV-positive partner maintains an undetectable viral load and both partners are free of sexually transmitted infections. The paper’s authors anticipate a similar extremely low risk of transmission during unprotected anal sex when the above conditions are met.

A report presented at the Third International Workshop on HIVand Women in Toronto that pooled data from six different studies—including the famed HPTN 052 trial—provided further proof of TasP’s success.

In contrast to the tightly controlled HPTN 052 trial, a new study of heterosexual straight couples in Uganda supplied proof of TasP in a real world setting. The researchers found that none of the people living with HIV transmitted to their partners if they were taking ARVs, compared with a considerable number of those off therapy who did.

Gus Cairns, the patient representative on the executive committee of the BHIVA, calls the current flow of research on TasP “overdue” and hails ARVs as “considerably more effective than any other prevention modality.”

Search: treatment as prevention, TasP, Expert Advisory Group on AIDS, British Advisory Association, HPTN 052, International Workshop on HIV and Women

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.